• Explore /
  • Poster
  • / Targeted next-generation sequencing (tNGS) of metastatic castrate-sensitive prostate cancer (M1 CSPC): A pilot molecular analysis in the STAMPEDE multi-center clinical trial.

Targeted next-generation sequencing (tNGS) of metastatic castrate-sensitive prostate cancer (M1 CSPC): A pilot molecular analysis in the STAMPEDE multi-center clinical trial.

Abstract Poster

Authors

null

Clare Gilson

MRC Clinical Trials Unit at UCL, London, United Kingdom

Clare Gilson , Fiona Ingleby , Duncan C Gilbert , Marina Parry , Nafisah B Atako , Malcolm David Mason , Zafar Malik , Ruth E Langley , Andrew Simmons , Andrea Loehr , Noel Clarke , Nicholas James , Mahesh K B Parmar , Matthew Robert Sydes , Gerhardt Attard , Simon Chowdhury

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 37, 2019 (suppl; abstr 5019)

DOI

10.1200/JCO.2019.37.15_suppl.5019

Abstract #

5019

Poster Bd #

131

Abstract Disclosures

Similar Posters

First Author: Mark Sausen

First Author: Justin Shaya

First Author: Aishwarya Subramanian

First Author: Siyuan S Guo